Cis-Retinoic acid

DRUG2 trials

Sponsors

Masonic Cancer Center, University of Minnesota, Centre Oscar Lambret

Conditions

LeukemiaWilms Tumor

Phase 1

Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation

TerminatedNCT00609739

Masonic Cancer Center, University of MinnesotaLeukemia

Start: 1999-06-30End: 2010-06-30Updated: 2017-12-28

Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)

RecruitingNCT05384821

Centre Oscar LambretWilms Tumor

Start: 2022-09-14End: 2028-10-01Target: 28Updated: 2026-03-18